Su-Jin Moon

Title: Innovative Contributions of Su-Jin Moon in Cell Therapy

Introduction

Su-Jin Moon is an inventor based in Seoul, South Korea, known for his groundbreaking research in immunology and stem cell therapy. With a keen focus on mesenchymal stem cells and their potential to treat immune disorders, his work has significant implications for medical science.

Latest Patents

Su-Jin Moon holds a patent titled "MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders." This patent centers around a novel preparation of rapamycin-treated mesenchymal stem cells that exhibit enhanced immunomodulatory activities. The specific features of these cells include the expression of various cell surface factors such as CCR1, CCR2, CCR3, CCR4, CCR7, CCR9, and CXCR4. The innovation presents a method for utilizing these cells in cell therapy, aiming to provide effective treatments for individuals suffering from immune disorders.

Career Highlights

Su-Jin Moon is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation, where he actively contributes to research and innovation in the field of stem cell therapy. His research has not only led to the patent but also advances the understanding of immune modulation through cellular mechanisms.

Collaborations

Throughout his career, Su-Jin Moon has collaborated with several researchers, including Chul Woo Yang and Mi-La Cho. These partnerships enhance the scope of his research and facilitate the exploration of innovative therapeutic approaches to treat immune-related diseases.

Conclusion

Su-Jin Moon's contributions to the field of cell therapy highlight the potential of mesenchymal stem cells in immunomodulation. His patented invention offers a promising avenue for preventing and treating immune disorders, showcasing the importance of innovation and collaboration in advancing medical science.